Synonyms: CKD-732 [2] | O-(4-(2-Dimethylaminoethoxy)-trans-cinnamoyl)fumagillol | ZGN 440 | ZGN-440
Compound class:
Synthetic organic
Comment: Beloranib is an investigational drug candidate for the treatment of obesity. The compound is a synthetic derivative of the antimicrobial agent fumagillin, from Aspergillus fumigatus. Beloranib is administered by subcutaneous injection.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] (E)-3-[4-(2-dimethylaminoethoxy)phenyl]prop-2-enoate |
International Nonproprietary Names ![]() |
|
INN number | INN |
9056 | beloranib |
Synonyms ![]() |
|
CKD-732 [2] | O-(4-(2-Dimethylaminoethoxy)-trans-cinnamoyl)fumagillol | ZGN 440 | ZGN-440 |
Database Links ![]() |
|
CAS Registry No. | 251111-30-5 |
GtoPdb PubChem SID | 252166655 |
PubChem CID | 6918502 |
Search Google for chemical match using the InChIKey | ZEZFKUBILQRZCK-MJSCXXSSSA-N |
Search Google for chemicals with the same backbone | ZEZFKUBILQRZCK |
Search PubMed clinical trials | beloranib |
Search PubMed titles | beloranib |
Search PubMed titles/abstracts | beloranib |
UniChem Compound Search for chemical match using the InChIKey | ZEZFKUBILQRZCK-MJSCXXSSSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ZEZFKUBILQRZCK-MJSCXXSSSA-N |